Laboratorios Liconsa competitive analysis

Latest publications and patents of Laboratorios Liconsa New

Explore the latest publications and patents granted to Laboratorios Liconsa, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Laboratorios Liconsa against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Dosage Regimen For A S1P Receptor AgonistNOVARTISMar 3, 2021
Stable Pharmaceutical Compositions Containing Sitagliptin In The Form Of Immediate Release TabletsGALENICUM HEALTH SLDec 23, 2020
Pharmaceutical Compositions Comprising An S1P ModulatorNOVARTISApr 3, 2020

Latest PTAB cases involving Laboratorios Liconsa

Discover the latest PTAB cases involving Laboratorios Liconsa, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Laboratorios Liconsa with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
LABORATORIOS LICONSA3 - - - Highly Aggressive
GALENICUM HEALTH SL112 - - Defensive
GALENICUM HEALTH SLU2712 - - Highly Aggressive
NOVARTIS6406 - 21Defensive